Squamocolumnar junction
Junction between squamous and columnar epithelium
- Plays an important role in development of the transformation zone
Main site for development of cervical cancer
Transformation zone
Development of transformation zone
During puberty -> increase in estrogen
Original SCJ moves outwards outwards (eversion of endocervix) -> exposes columnar epithelium to the outside acidic vaginal environment -> cervical ectropion
‘Harsh’ environment of vagina promotes squamous metaplasia (of what is the exposed columnar epithelium) -> formation of new SCJ
Transformation zone: region bound by original and new SCJ
Human Papillomavirus (HPV)
Double stranded DNA virus
HPV 16 + 18 a/w cervical ca
Important facts about HPV infection
What does persistent infection mean?
Inability of body to get rid of HPV infection leading to chronic infection that eventually develops into pre-cancer then cancer over time
Risk factors of cervical ca
Increase exposure to HPV infection
- HPV infection (16/18) ++
- Multiple sexual partners
- Early age of 1st coitus < 20y/o
Reduce ability for body to eradicate HPV infection
- STI
- Smoking
- Immunosuppression
Primary prevention of cervical ca
HPV vaccination
- prevent infection from high risk HPV
Secondary prevention of cervical ca
Pap smear, HPV DNA test
- Detects presence of abnormal cells (pap)
- Detects presence of virus (HPV DNA test)
KIV Colposcopy (diagnostic test)
- Detects CIN and treatment to prevent from progressing to cancer
Pap smear
DETECTION OF CIN
- Liquid based cytology to look for abnormal cells
- SCREENING test
- For asymptomatic women
- Cervical pre-cancers are asymptomatic
- Helps with risk stratification
Sensitivity of Pap smear test
50%
Management of Pap smear result (normal women)
All cytology results require refer to colposcopy except
1. Negative for intra-epithelial lesion and malignant cells
2. Atypical squamous cells of undetermined significance (ASC-US)
- Repeat PAP in 6 months and only refer to colposcopy after 2x ASCUS
Management of HPV DNA test results
*For immunocompromised women -> ALL HPV positive results refer to colposcopy
HPV DNA testing in cervical ca screening
DETECTION OF CIN
- Objective test
- SCREENING test
- HPV 16/ 18 via the Roche Cobas test
- Higher sensitivity (strong negative predictive value)
- Helps with risk stratification
2 types of HPV DNA test available
Cervical ca screening methods
For all women who ever had sexual intercourse
25-29 y/o: PAP smear every 3 years
30-69 y/o: HPV test alone every 5 years
Cervical ca screening for immunocompromised women
For all immunocompromised women who ever had sexual intercourse
- ALL women with history of HIV
- ALL women with history of solid organ transplant
- Women on more than 2 immunosuppressants meds
25-29 y/o: PAP smear yearly
≥30 y/o: HPV test every 3 years
What is HPV vaccine?
Types of HPV vaccine
1: Cervarix (protects from HPV 16, 18)
2: Gardasil (protects from HPV 16, 18, 6, 11)
3: Gardasil 9 (protects from HPV 16, 18, 6, 11 + 5 more HPV types)
Why is there a need for HPV vaccine?
Highly effective in preventing cervical pre-cancer
How good is the HPV vaccine?
Is the HPV vaccine safe?
Safe
- Common S/E: pain, swelling and redness at injection site
How is the HPV vaccine given?
Dosing regimen for HPV vaccine
Age 9 to 14 years old:
2 dose regime (0 and 6 months)
Age 15 years old and above:
3 dose regime (0, 1-2 and 6 months)